Skip to content

Merit Medical Systems MMSI Single Reportable — Sales & Marketing

Similar metrics at other companies

Axcelis Technologies logo
ACLSSingle Reportable — Sales & Marketing
$17.35M+14.7%
Boot Barn Holdings logo
BOOTSingle Reportable — Sales & Marketing
$103.9M+22.9%
Celsius Holdings, Inc. logo
CELHReportable Segment — Sales & Marketing
$150.59M+86.2%
Veracyte logo
VCYTReportable Segment — Sales & Marketing
$27.16M+11.0%
Powell Industries logo
POWLReportable Segment — Sales and marketing expenses
$8.37M+20.7%
Waystar Holding Corp. logo
WAYReportable Segment — Sales and marketing
$45.83M+14.2%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's single reportable — sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's single reportable — sales & marketing?
Merit Medical Systems (MMSI) reported single reportable — sales & marketing of $73.96M in Q1 2026.
What does single reportable — sales & marketing mean?
This metric tracks the costs incurred for sales commissions, advertising, and promotional activities dedicated to the segment's product portfolio. It provides insight into the company's investment in customer acquisition and brand positioning within the competitive medical device market. High levels of this expense relative to revenue may indicate aggressive growth strategies or increased competitive pressure.